International Cancer Research Partnership |

Partner Virtual Meeting - January 2022

Read more about Partner Virtual Meeting - January 2022

January 20, 2022 7:00 AM (EST) - January 20, 2022 8:00 AM (EST)

Webex, online

ICRP Jan 2022 Partner Meeting

https://icrp.webex.com/icrp/j.php?MTID=mfbdb820e99cce8ed77cc8a5c63988d6f
Thursday, Jan 20, 2022 12:00 pm | 1 hour | (UTC+00:00) Dublin, Edinburgh, Lisbon, London
Meeting number: 137 190 1361
Password: 4321

Join by video system
Dial 1371901361@icrp.webex.com
You can also dial 62.109.219.4 and enter your meeting number.

Join by phone
0800-051-3810 Call-in toll-free number (UK)
+44-203-478-5289 Call-in toll number (UK)
Access code: 137 190 1361

Meeting papers in the ICRP Library

Annual Meetings

Survivorship Working Group (Option 2)

Read more about Survivorship Working Group (Option 2)

December 16, 2021 11:00 AM (EST) - December 16, 2021 12:00 PM (EST)

Webex, online

ICRP Survivorship analysis: option 2

https://icrp.webex.com/icrp/j.php?MTID=mfa1c17fc02a724f81c961c7988e8d754
Thursday, Dec 16, 2021 4:00 pm | 1 hour | (UTC+00:00) Dublin, Edinburgh, Lisbon, London
Meeting number: 2404 257 2492
Password: 4321

Join by video system
Dial 24042572492@icrp.webex.com
You can also dial 62.109.219.4 and enter your meeting number.

Join by phone
0800-051-3810 Call-in toll-free number (UK)
+44-203-478-5289 Call-in toll number (UK)
Access code: 240 425 72492

Evaluations and Analyses

Survivorship Working Group (Option 1)

Read more about Survivorship Working Group (Option 1)

December 13, 2021 11:00 AM (EST) - December 13, 2021 12:00 PM (EST)

Webex, online

ICRP Survivorship analysis: option 1

https://icrp.webex.com/icrp/j.php?MTID=mcb735f1598660c787344195253370e62
Monday, Dec 13, 2021 4:00 pm | 1 hour | (UTC+00:00) Dublin, Edinburgh, Lisbon, London
Meeting number: 2393 103 3577
Password: 4321

Join by video system
Dial 23931033577@icrp.webex.com
You can also dial 62.109.219.4 and enter your meeting number.

Join by phone
0800-051-3810 Call-in toll-free number (UK)
+44-203-478-5289 Call-in toll number (UK)
Access code: 239 310 33577

Evaluations and Analyses

ICRP Partner meeting November 2021

Read more about ICRP Partner meeting November 2021

November 18, 2021 6:00 PM (EST) - November 18, 2021 8:00 PM (EST)

https://icrp.webex.com/icrp/j.php?MTID=mea0af7934d5cfe82d9267b315c0f3366

Webex meeting for November 2021

Agenda and paper here: https://www.icrpartnership.org/library?nodeId=6#

Ways to join:

Join from the meeting link

https://icrp.webex.com/icrp/j.php?MTID=mb5bdf617f5b10e01625bb37bc35d2604

Join by meeting number

Meeting number (access code): 137 516 5176

Meeting password: 4321

Join by phone

0800-051-3810 Call-in toll-free number (UK)

+44-203-478-5289 Call-in toll number (UK)

Global call-in numbers | Toll-free calling restrictions

Join from a video system or application

Dial 1375165176@icrp.webex.com

You can also dial 62.109.219.4 and enter your meeting number.

Join using Microsoft Lync or Microsoft Skype for Business

Dial 1375165176.icrp@lync.webex.com

If you are a host, click here to view host information.

Need help? Go to https://help.webex.com

Partner Operations

ASCO 2021 - Virtual

Read more about ASCO 2021 - Virtual

June 4, 2021 8:00 AM (EDT) - June 8, 2021 5:00 PM (EDT)

Virtual

Your unique and unparalleled opportunity to stay up to date on the latest in cancer care and connect with the largest, most diverse community in oncology. Register now to get the best rates (early registration ends April 28).

Register Today

Conference/Meeting

Special Focus Dialogue on Tobacco Control and Cancer

Read more about Special Focus Dialogue on Tobacco Control and Cancer

May 12, 2021 9:00 AM (EDT) - May 12, 2021 10:00 AM (EDT)

Virtual

UICC Special Focus Dialogue on Tobacco Control and Cancer with the participation of the WHO FCTC, the Framework Convention Alliance and the King Hussein Cancer Center, scheduled on May 12, 2021 15:00 Zurich (check your time here)

Please register here

This dialogue, moderated by Leslie Rae Ferat (Executive Director of FCA) will take place between Prof. Anil D'Cruz (President of the Union for International Cancer Control), Dr Adrianna Blanco Marquizo (Head of the WHO FCTC) and Dr Nour Obeidat (Head of Cancer Control Office, King Hussein Cancer Center).

The first virtual dialogue of tobacco control and cancer series will introduce multiple ideas:

-How to strengthen and synergize efforts between cancer and tobacco control communities in order to help the advance of both agendas.

-How the cancer control and NCD communities can help to accelerate the implementation of the WHO FCTC and how this will lead to a decrease in tobacco prevalence and ultimately the cancer incidence.

Webinar

Melanoma Research Alliance (MRA) 2022 Scientific Retreat

Read more about Melanoma Research Alliance (MRA) 2022 Scientific Retreat

March 9, 2022 8:00 AM (EST) - March 11, 2022 5:00 PM (EST)

Washington, DC, USA

The MRA Scientific Retreat is an invitation-only meeting of MRA grantees. If any ICRP member is interested, please reach out to MRA scientific staff. The event includes 4 or 5 scientific sessions, with each incluing a keynote lecture and then short grantee interim-progress updates. The event also includes panel discussions, poster sessions, and networking roundtables (around scientific themes/areas of interest).

Conference/Meeting

ICRP Partner Meeting March 2021

Read more about ICRP Partner Meeting March 2021

March 18, 2021 11:00 AM (EDT) - March 18, 2021 12:00 PM (EDT)

Webex, online

Details for joining the next partner webinar are included below. Papers can be accessed from ICRP library folder. If you can’t make the meeting but want to share any news, please feel free to email and we’ll share on the call! If you have any questions, just email Lynne.

Forthcoming meetings are:

Partner webinar: Thu March 18th – details below
ICRP-NCRI Virtual Meeting: Mon March 22nd “Addressing disparities in international cancer research” – Free registration is open, please do circulate to any colleagues who may be interested.

ICRP Partners 18 March 2021

https://icrp.webex.com/icrp/j.php?MTID=m5882b617377abb00f0c24d16d91e3012

Thursday, Mar 18, 2021 11:00 am | US EDT

Meeting number: 183 011 0907
Password: 4321

Join by video system

Dial 1830110907@icrp.webex.com
You can also dial 62.109.219.4 and enter your meeting number.

Join by phone

0800-051-3810 Call-in toll-free number (UK)
+44-203-478-5289 Call-in toll number (UK)
Access code: 183 011 0907
Global call-in numbers | Toll-free calling restrictions

Partner News and Announcements

Virtual Event: Exploring Global Partnerships in Cancer Research

Read more about Virtual Event: Exploring Global Partnerships in Cancer Research

February 18, 2021 7:00 AM (EST) - February 18, 2021 8:00 AM (EST)

Online (NCRI Events)

This meeting is instead of the usual February Partner Webinar. Registration (free) is required: CLICK HERE TO REGISTER

Summary

This session aims to explain more about the benefits of collaboration between international cancer research funders. Hear from a selection of organsations who have set up successful international collaborative funding opportunities to address gaps in cancer research, including Cancer Research UK, US National Cancer Institute Center for Global Health, Worldwide Cancer Research, Cancer Australia and the World Cancer Research Fund International. The panel will discuss the impact of COVID-19, opportunities for future collaborations and discuss best practice in establishing international collaborative funding streams.

Who should attend?

Cancer research funding organizations’ representatives
Policy makers
Advocacy groups interested in cancer research funding

Contributing organisations

Cancer Research UK, UK
Worldwide Cancer Research, UK
National Cancer Research Institute, UK
World Cancer Research Fund International, UK
Cancer Australia, AU
Melanoma Research Alliance, US
National Cancer Institute Center for Global Health, US

Annual Meetings

ICRP Partner Meeting November 2020

Read more about ICRP Partner Meeting November 2020

November 17, 2020 11:00 AM (EST) - November 17, 2020 1:00 PM (EST)

Webex, online

Thursday, November 19, 2020, 11:00 – 12.00 US Eastern Daylight Time (ET)*

*Equates to 08.00 US Pacific, 16.00 UK, 17.00 CET, Fri 20: 01.00 Japan, 03.00 Eastern Australia

Note: please join the call only if it is convenient in your time zone!

Online meeting: https://icrp.webex.com/icrp/j.php?MTID=mfc981e594c701139bfc0dd0e5f79f32b

Meeting number: 174 027 2914 Meeting password: 4321

If you need to call in using a phone, you can use the numbers listed in the agenda (note, you can use a phone and also see the online meeting, or you can use your computer for audio – best with headphones to avoid feedback).

For all meeting papers, click here.

Partner Operations

Subscribe to

Single-funder organizations
Partner	Caveat
ACS	Dollar amounts found in the ICRP database are different than what is reported in the American Cancer Society's Annual Report. The dollar amounts spent on research reported in audited reports include operating expenses of the Research Department. Additionally, the dollar amounts also exclude all grants that were cancelled after being awarded, but include money that was returned from grants cancelled in the current year that were awarded in previous years. The dollar amounts reported in the database are unaudited and include grants awarded each fiscal year, exclusive of grants that cancelled before activation.
CBCRP	The California Breast Cancer Research Program grants are awarded only to individuals or institutions in California. Grants to the University of California receive only direct funds, while grants to other institutions also receive indirect costs (overhead) at 25% or the federally negotiated rate. Collaborative awards are counted in graphs and tables by the number of co-Principal Investigators rather than the number of projects.
Komen	Dollar amounts found in the ICRP database are different than what is reported on Komen\'s website or in Komen\'s Annual Report for the following reasons: Komen commits all funds necessary to support a research grant in the year it is awarded. Therefore, Komen\'s website reports on the full amount of each grant in the year it is initiated, while the ICRP data is annualized, as described. Komen funds research grants to our Scientific Advisors (Scientific Advisory Board members and Komen Scholars) and also provides discretionary funding of research-related projects that are not traditional research grants (e.g. support of the Komen Tissue Bank, ASCO and AACR meeting support). These are included in the overall Research Program spending, as reported in our Annual Report and on our website, but are not included in the ICRP database.
NIH	NIH projects in NIH Reporter assigned to the Spend Category ‘cancer’ are included in the ICRP database from FY2005 onwards. A small number of projects are excluded if essential information is missing (primarily Project title, Institution). Previous years’ data were drawn from the NFRP and may be incomplete. Starting in FY2007 NCI reports funding supplements, etc., for each grant separately instead of including them in the main project, therefore the number of projects may differ significantly from those of previous years. Projects with a cost of $0 include those that were a no-cost extension of the grant or when funding was provided by another NIH institute or center for that FY. NCI dollars in the ICRP database are drawn from NIH reporter and may not match dollars from other NCI-only databases.
Worldwide Cancer Research	Worldwide Cancer Research is unique in that the majority of our funding is awarded to researchers in countries outside the UK. Like many UK research charities, Worldwide Cancer Research only funds the direct costs of research. This creates significant problems in making quantitative comparisons between our funding and that provided by some of the other agencies in the ICRP, which fund both the direct and indirect costs (often called overheads) of research.

UK Organizations that are part of NCRI
Partner	Caveat
NCRI (GENERIC)	NCRI submits data to ICRP on behalf of all UK NCRI members from its Cancer Research Database (CaRD). The database only includes entries where funding can be directly attributed to a set of clearly defined research objectives. This means that the CaRD only contains information on all direct research funding (project, programme, fellowship, unit and institute) financed by NCRI Member organizations, for which an abstract has been submitted and where the project is active in any given financial year (April - March). Examples of funding that are currently outside the scope of CaRD are infrastructure, meeting grants and research management support."
Breakthrough (UK)	The ICRP database includes all Breakthrough Breast Cancer\'s research spend reported through its Annual Reports & Accounts. There is some variance due to different reporting periods (1 April snapshot versus full financial year) meaning that some research spend that is already committed may not be included in the ICRP figures. Expenditure on non-research charitable activities and management support costs are excluded from the NCRI, and by extension, the ICRP dataset. For further information on Breakthrough\'s research please visit www.breakthroughresearch.org.uk or email research@breakthrough.org.uk
CR-UK (UK)	The ICRP database includes around 70% of Cancer Research UK\'s direct research spend per financial year as reported through its Annual Reports & Accounts. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on vital research services, technology transfer, meeting grants, research management support and infrastructure to support Cancer Research UK\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Department of Health (UK)	There will always be some variance between the figures available on ICRP and the figures reported publicly by DH. There are two reasons for this. Firstly, there is variance due to different reporting periods (1 April snapshot of ICRP versus full financial year reporting by DH). Secondly, the Department\'s National Institute for Health Research (NIHR) encompasses various expenditure on NHS infrastructure for research relevant to cancer that is not in a format that it is possible to capture for ICRP.
Macmillan (UK)	The ICRP database represents about 90% of Macmillan Cancer Support\'s direct research spend per financial year. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on research management support and infrastructure to support Macmillan Cancer Support\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Scottish Government Health Directorates (UK)	Scottish Government is committed to improve the health of the Scottish population and the Chief Scientist\'s Office (CSO) funds across a broad range of relevant disease areas. Overall, 75% of the CSO spend is committed to research infrastructure in NHS Scotland. This and much other research expenditure is therefore outside the NCRI remit and, by extension, the ICRP dataset.

Canadian organizations who are part of the CCRA
Partner	Caveat
CCRA	Caveats/limitations specific to Canadian Cancer Research Alliance organizations can be accessed here.

Difference	Detail	Impact on investment figures
Not all CCRS participating organizations are included in the ICRP.	For the period 2005–2021, CCRA submitted data to the ICRP for 35 organizations and three now defunct multi-funded initiatives (CBCRA, CPCRI, and CTCRI). Note that the Canadian Breast Cancer Research Foundation merged operations with the Canadian Cancer Society in February 2017 and Prostate Cancer Canada merged in 2020. Importantly, Alberta Innovates did not report any research projects for 2020 and 2021 due to staffing constraints. Projects within the CCRS total 30,218, of which 24,129 were reported to ICRP.	Moderate for years 2020 and 2021
Not all CCRS projects are included in the ICRP.	“Related support” grants (i.e., travel awards, workshops/symposia, LOIs, etc.) are not submitted to ICRP, but are included in reports released by CCRA. In addition, equipment/infrastructure grants through the Canada Foundation for Innovation and for other funders where the cancer relevance weighting is less than 80% are not reported to the ICRP, but are included in CCRA reports. Any project with cancer relevance of less than 20% is also not reported to the ICRP.	Moderate
Co-funded projects are listed by the administering organization.	Projects that are co-funded appear under the administering organization and are not duplicated per funder. Within CCRA reports, however, investments are reported by the actual funders.	Minor
ICRP uses a different approach to calculating annual project investment.	CCRA provides ICRP with the project budget (adjusted for cancer relevance) and start and end dates. A pro-rated calculation is used to derive annual investment. Within the CCRS, prorated calculations on the basis of annual project amounts (where those data are available) are used to calculate the annual investment.	Minor
ICRP uses different site coding conventions.	The cancer site/type codes used within the CCRS are different from ICRP site codes so results by site will vary in some instances.	Minor
ICRP has technical limitations.	ICRP has a technical limit of 12 site codes and 8 CSO codes and this requires truncation for a couple of large-scale projects within the CCRS.	Very minor
CCRA provides less descriptive information about its projects to ICRP.	Lay abstracts are submitted by CCRA to the ICRP in lieu of technical abstracts and in their language of origin. For projects without lay abstracts (and there are a significant number of these), only titles are provided. An English translation is provided alongside all French project titles to facilitate use of the search engine.	No impact on investment figures, but limits full functionality of search engine especially for organizations that do not collect/report lay abstracts.